The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Figure 4 from Cannabinoid Discrimination and Antagonism by CB1 Neutral and Inverse Agonist Antagonists

Analysis of Tolerance and Behavioral/Physical Dependence during

Full article: A comprehensive patents review on cannabinoid 1

Effects of acute AM4113 (60-minute pretreatment time) on food and

Cells, Free Full-Text

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. - Abstract - Europe PMC

Effects of the cannabinoid CB1-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male rats - ScienceDirect

Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research

DDC, Free Full-Text